Concepedia

Publication | Open Access

Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis

201

Citations

22

References

2020

Year

Abstract

ClinicalTrials.gov Identifier: NCT02672852.

References

YearCitations

Page 1